DRUG

Bright Minds Biosciences Inc.

Company with tickers: DRUG

CIK

1827401

CUSIP

10919W405

Shares Outstanding

4,524,087

Website

https://brightmindsbio.com

13F Activity (30d)

4 filings 3 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Date	Event	Type
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-03-04	TD Cowen 46th Annual Health Care Conference	Conference
2026-01-06	Topline results for Phase 2 trial of BMB-101 in patients with drug-resistant Absence Seizures and Developmental and Epileptic Encephalopathy	Event
2025-11-17	Jefferies Global Healthcare Conference in London	Conference
2025-11-12	Guggenheim 2nd Annual Healthcare Innovation Conference	Conference
2025-11-06	Bright Minds Prader-Willi Syndrome (PWS) Program KOL Event	Event
2025-06-05	2025 Jefferies Global Healthcare Conference	Conference
2025-05-20	Bright Minds Biosciences Absence Epilepsy R&D Day	Event
2025-03-03	TD Cowen 45th Annual Health Care Conference	Conference
2024-12-10	American Epilepsy Society 2024 Annual Meeting	Shareholder meeting
2024-11-07	Chicago BioCapital Summit	Event
2024-11-06	Bio-Europe	Event
2024-10-09	Society for Neuroscience Annual Meeting	Shareholder meeting
2024-09-25	Bright Minds Biosciences BMB-101 Phase 2 study Announcement & KOL Event	Event